Results 131 to 140 of about 5,853,531 (371)

State Litigation during the Obama Administration: Diverging Agendas in an Era of Polarized Politics [PDF]

, 2014
Throughout the Obama Administration, state attorneys general (AGs) have collaborated on several high-profile political issues. To get a fuller picture of this contemporary AG activism, this article analyzes AG participation in lawsuits and amicus curiae ...
Nolette, Paul
core   +1 more source

Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data

Molecular Oncology, EarlyView.
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu, Katherine Eason, Suet‐Feung Chin, Paul A. W. Edwards, Raquel Manzano Garcia, Richard Moulange, Jia Wern Pan, Soo Hwang Teo, Sach Mukherjee, Maurizio Callari, Carlos Caldas, Stephen‐John Sammut, Oscar M. Rueda   +12 more
wiley   +1 more source

The Qualitative Governmental Interest Analysis: New York's Conflict of Laws Rules in Transition: George v. Douglas Aircraft Co.

, 1965

openalex   +2 more sources

Elevated MIA Serum Levels are of Relevance for Management of Metastasized Malignant Melanomas: Results of a German Multicenter Study11The authors declared in writing to have no conflict of interest. [PDF]

, 2000
Anja‐Katrin Bosserhoff, Rüdiger Hein, Reinhard Buettner, Axel Hauschild, Dirk Schadendorf, Eggert Stockfleth, Thomas Bogenrieder, Michael Landthaler, Wilhelm Stolz   +8 more
openalex   +1 more source

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

Molecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci, Izzet Akiva, Yavuz Hakan Ozon, Hakan Berkil, Huseyin Karadayi, Omer Dizdar, Suayib Yalcin   +6 more
wiley   +1 more source

Ethics Review for Sale? Conflict of Interest and Commercial Research Review Boards [PDF]

, 2000
Trudo Lemmens, Benjamin Freedman
openalex   +1 more source

Conflict of interest and compliance [PDF]

, 2010
Hiramatsu, Yuji
core   +1 more source

Post-Employment, “Revolving Door,” Laws for Federal Personnel [PDF]

, 2012
[Excerpt] Conflict of interest regulations and restrictions on certain private employment opportunities for a federal officer or employee do not necessarily end with the termination of the officer’s or employee’s federal service.
Maskell, Jack
core   +2 more sources

Data‐driven discovery of gene expression markers distinguishing pediatric acute lymphoblastic leukemia subtypes

Molecular Oncology, EarlyView.
This study investigates gene expression differences between two major pediatric acute lymphoblastic leukemia (ALL) subtypes, B‐cell precursor ALL, and T‐cell ALL, using a data‐driven approach consisting of biostatistics and machine learning methods. Following analysis of a discovery dataset, we find a set of 14 expression markers differentiating the ...
Mona Nourbakhsh, Nikola Tom, Anna Schrøder Lassen, Helene Brasch Lind Petersen, Ulrik Kristoffer Stoltze, Karin Wadt, Kjeld Schmiegelow, Matteo Tiberti, Elena Papaleo   +8 more
wiley   +1 more source

Federal Civil Procedure: Consolidation of Negligence Actions Inappropriate Where Lead Counsel Order Aggravates Conflict of Interest between Plaintiffs

, 1967

openalex   +2 more sources